RESONANCE HEALTH LIMITED (RHT)

---

AI Coverage Rating: Moderate

ASX AI Signals has generated 2 signal(s) for RHT during the last 90 days, indicating Moderate trading activity

Latest RHT Signals
17/06/2026	BUY
16/06/2026	SELL
RHT Share Price
Current Price	$0.044
52 Week High	$0.055
52 Week Low:	$0.033
Trading at (% of 52 Week High)	80.00%

Business Overview

Resonance Health Limited (ASX: RHT) specializes in medical imaging technology and health diagnostics. The company develops non-invasive software tools for measuring iron levels in the body, primarily to support patients with iron overload disorders. Their solutions assist clinicians in diagnosis and treatment planning.

ASX Sector Overview

Sector:   Health Care Equipment & Services

The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.

Latest AI Recommendation

The BUY signal for RESONANCE HEALTH LIMITED (RHT) is supported by potential undervaluation at a low price point, but overall confidence is limited due to the stock's low liquidity, limited market presence, and lack of recent positive catalysts.

Latest  RESONANCE HEALTH LIMITED(RHT)   News